0
Obstructive Lung Diseases |

The Survey on the Current Status of Comorbidity About COPD (Chronic Obstructive Pulmonary Disease) Patients Burden in Rural Areas of Japan

Tomoyasu Uno, MD
Author and Funding Information

Health Care Center, Fukushima University, Japan, Fukushima-City, Fukushima Prefecture, Japan


Chest. 2014;145(3_MeetingAbstracts):392A. doi:10.1378/chest.1834135
Text Size: A A A
Published online

Abstract

SESSION TITLE: COPD Comorbidity Posters

SESSION TYPE: Poster Presentations

PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM

PURPOSE: Comorbidities with COPD (Chronic Obstructive Pulmonary Disease) is one of the most important problems. Previous reports suggested that systemic inflammation may be the link between COPD and comorbidities, but this issue is still low debated in Japan. Whatever the mechanism of comorbidities may be, it has important clinical, prognostic and therapeutic problems. In this study, investigated for the evaluation and measures about COPD burden patients of the current situation in rural area Japan. And also aimed that through comorbidities, contributes to improving patients care and COPD awareness.

METHODS: Subjects (n=40) in this survey conducted in who have regularly outpatient in a certain rural area hospital that had diagnosed COPD patients. Investigation strategy was using a questionnaire (Self fill out) survey and face-to-face methods. Main questionnaire items were sex, age, smoking history, smoking ratio, comorbidity type and the number of patients, awareness of COPD and Lung age.

RESULTS: COPD burden patient’s characteristics were Male/Female: 95.0%/5.0%, Age: 70.1±10.3 [mean±SD]. 82.5% of patients had the comorbid disease. COPD burden patients, which accounts for the top with Hypertension (35.0%), Gastrointestinal diseases (27.5%), Diabetes (25.0%), had been comorbid, especially the upper gastrointestinal tract ulceration (. The most number of patient's comorbidities were 2 (35.0%, Age: 72.4±10.3 [mean±SD]). Maximum number were 6 (5.0%). Hypertension, Cancer were one of the most comorbidities. During the observation period, do the treatment of each disease, acute exacerbation of COPD was not observed. Also, no apparent rapid worsening of comorbidities.

CONCLUSIONS: In this study showed that many comorbidities were observed, we should sufficient management and re-recognized as a systemic diseases. Thus we were considered that necessary to build a better multidimensional treatment strategy for comprehensive assessment of COPD with comorbidities.

CLINICAL IMPLICATIONS: Comorbidities with COPD (Chronic Obstructive Pulmonary Disease) is a very important problem. We were considered that necessary to build a better multidimensional treatment strategy for comprehensive assessment of COPD with comorbidities

DISCLOSURE: The following authors have nothing to disclose: Tomoyasu Uno

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543